by Ruchita Sinha | Aug, 2022 | General
We are excited to announce our latest investment in Think Bioscience. Think falls squarely in the middle of AV8’s life science investment thesis to invest in novel platforms that combine computational approaches with a strong understanding of biology. Think Bioscience...
by Ruchita Sinha | Sep, 2021 | General
AV8 is no stranger to Myong Lee and Clever Care. We have been tracking the company ever since they raised their Series A in 2020. As any healthcare investor likely knows, Medicare Advantage (MA) is a $300B+ market that has more than doubled over the past decade. In...
by Ruchita Sinha | Jul, 2021 | General
At times we come across a topic where AV8’s healthcare and enterprise practices augment each other. Digitization and workforce development in healthcare is one of these topics that we have been studying with an eye towards finding companies that improve the cost and...
by Ruchita Sinha | May, 2021 | General
The past 12 months have by no means been ordinary for the healthcare innovation ecosystem. Whether it is the jaw-dropping $6.7B that went into startups in Q1 2021, the 8 IPOs of digital health companies in 2020, or the 11 SPAC mergers completed or announced in Q1...
Recent Comments